Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 187

Sort by

Sort Order Select

Journal Articles

Rapid Dose Escalation of Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Previously Treated with B-Cell Receptor Inhibitor Therapy

Kristin Koenig, MD, Emily Dotson, PharmD, Shane Sheredy, Seema A. Bhat, MD, John C. Byrd, MD, Tracy Wiczer, Jennifer Woyach, MD, Farrukh T. Awan, MD, Kerry A. Rogers, MD

Blood (2019) 134 (Supplement_1): 3045.

https://doi.org/10.1182/blood-2019-124538

Published: 2019

Journal Articles

XPO1 Mutations May Identify Binet Α Chronic Lymphocytic Leukemia Patients with Shorter Time to First Treatment

Riccardo Moia, MD, Chiara Favini, MSc, Sruthi Sagiraju, Valeria Spina, PhD, Alessio Bruscaggin, PhD, Silvia Rasi, Lorenzo De Paoli, Clara Deambrogi, PhD, Mattia Schipani, Ahad Ahmed Kodipad, Davide Rossi, MD PhD, Gianluca Gaidano, MD PhD

Blood (2019) 134 (Supplement_1): 1743.

https://doi.org/10.1182/blood-2019-126054

Published: 2019

Journal Articles

Genomic Abnormalities Among African Individuals with Monoclonal Gammopathies Using Calculated Ancestry

Linda B Baughn, PhD, Dirk Larson, MS, Mei-Yin Polley, PhD, Kathryn E. Pearce, Eran Elhaik, PhD, Michael L. Baird, PhD, Colin Colby, Joanne Benson, Zhou Li, MS, Yan Asmann, PhD, Terry Therneau, PhD, James R. Cerhan, MD PhD, Celine M. Vachon, PhD, A Keith Stewart, MB, ChB, P. Leif Bergsagel, MD, Angela Dispenzieri, MD, Shaji K. Kumar, MD, S. Vincent Rajkumar, MD

Blood (2018) 132 (Supplement 1): 4458.

https://doi.org/10.1182/blood-2018-99-117382

Published: 2018

Journal Articles

T Cell Large Granular Lymphocytic Leukemia and Co-Existing Plasma Cell Disorders

M Hasib Sidiqi, MBBS, Mohammed A Aljama, MBBS,FRCPC, David S. Viswanatha, MD, David Dingli, MD PhD

Blood (2018) 132 (Supplement 1): 5368.

https://doi.org/10.1182/blood-2018-99-114953

Published: 2018

Journal Articles

The Role of Molacular Genetic Examination in Differential Diagnosis and Prognostic Prediction in Patints with B-Cell Chronic Lymphoproliferative Disorders: A Restrospective Study of 1592 Patients

Yuting Yan, Wenjie Xiong, Shuhua Yi, MD, Li Zengjun, Dehui Zou, MD, Weiwei Sui, Wei Liu, Tingyu Wang, Lugui Qiu, Sr., MD PhD

Blood (2018) 132 (Supplement 1): 5329.

https://doi.org/10.1182/blood-2018-99-114920

Published: 2018

Journal Articles

Droplet Digital PCR for the Quantification of Alu Methylation Status in Hematological Malignancies

Paola Orsini, Luciana Impera, Elisa Parciante, Cosimo Cumbo, Crescenzio Francesco Minervini, Angela Minervini, Luisa Anelli, Antonella Zagaria, Nicoletta Coccaro, Paola Casieri, Giuseppina Tota, Claudia Brunetti, Alessandra Ricco, MD, Paola Carluccio, Giorgina Specchia, MD, Francesco Albano, MD

Blood (2018) 132 (Supplement 1): 2612.

https://doi.org/10.1182/blood-2018-99-115966

Published: 2018

Journal Articles

Cell-Free DNA Analysis Demonstrates Comprehensive Genomic Profiling and a Facile Method to Sensitively in Multiple Myeloma

Juan Du, MD PhD, Jing Lu, Wanting Qiang, Lu Li, Jin Liu, Hua Jiang, MD, Ziliang Qian, PhD, Baoan Chen, MD PhD, Weijun Fu, MD PhD

Blood (2018) 132 (Supplement 1): 5603.

https://doi.org/10.1182/blood-2018-99-116260

Published: 2018

Journal Articles

Predictors of Patient-Reported Communication with Their Health Care Team about New Treatment Options for Chronic Lymphocytic Leukemia

Julie Olson, PhD, Joanne S. Buzaglo, PhD, Shauna McManus, BS, Linda House, RN, BSN, MSM, Thomas W. LeBlanc, MD MA

Blood (2018) 132 (Supplement 1): 5870.

https://doi.org/10.1182/blood-2018-99-118996

Published: 2018

Journal Articles

Chronic Lymphocytic Leukemia Patients with IGH Rearrangements Are Characterized By a Distinct Genetic Landscape with Prognostic Implications

Blood (2018) 132 (Supplement 1): 3129.

https://doi.org/10.1182/blood-2018-99-115959

Published: 2018

Journal Articles

Risk of Engraftment Syndrome after Autologous Stem Cell Transplantation for Multiple Myeloma Increases with Age and Lower Dose of CD34+ Cells, but Is Not Impacted By Immunomodulatory Chemotherapy

Phyllis McKiernan, APN, MSN, David Siegel, MD PhD, Scott D. Rowley, MD, David H. Vesole, MD PhD, Tracy Andrews, PhD, Andrea Ortega, RN, Alan P Skarbnik, MD, Noa Biran, MD, Joshua R Richter, MD, Andrew L. Pecora, MD, Andre Goy, MD, Rima M Panchal, MD, Nino Aleksidze, MD, Michele L. Donato, MD

Blood (2017) 130 (Supplement 1): 3284.

https://doi.org/10.1182/blood.V130.Suppl_1.3284.3284

Published: 2017

Journal Articles

Chronic Lymphocytic Leukemia with Deletion 13q: Prognostic Predictors and Outcome after Treatment with Fludarabine, Cyclophosphamide and Rituximab (FCR)

Abdul Rashid Shah, MD, Tariq Muzzafar, MBBS, Romana Asad, MD, Christine B Peterson, Hagop M. Kantarjian, MD, Alessandra Ferrajoli, MD, William G Wierda, MD PhD, Jan A. Burger, MD PhD, Nitin Jain, MD, Gautam Borthakur, MD, Maliha Khan, MD, Abhishek Chilkulwar, MD, Brion Randolph, MD, Lohith Gowda, MD, Michael J Keating

Blood (2017) 130 (Supplement 1): 5337.

https://doi.org/10.1182/blood.V130.Suppl_1.5337.5337

Published: 2017

Journal Articles

Outcomes of Autologous Stem Cell Transplantation in Very Elderly Patients with Multiple Myeloma

Phyllis McKiernan, APN, MSN, David Siegel, MD PhD, David H. Vesole, MD PhD, Scott D. Rowley, MD, Tracy Andrews, PhD, Andrea Ortega, RN, Alan P Skarbnik, MD, Noa Biran, MD, Joshua R Richter, MD, Andrew L. Pecora, MD, Andre Goy, MD, Rima M Panchal, MD, Nino Aleksidze, MD, Michele L. Donato, MD

Blood (2017) 130 (Supplement 1): 2013.

https://doi.org/10.1182/blood.V130.Suppl_1.2013.2013

Published: 2017

Journal Articles

Targeted Deep Sequencing in Untreated Progressive CLL Helps to Better Dissect the Genomic Landscape and Shows Novel Associations between Mutations, Prognostic and Clinical Parameters: Data from E1912, a Randomized Phase III Study of the ECOG-ACRIN Cancer Research Group

Esteban Braggio, PhD, Victoria Wang, Laura Ann Bruins, BS, Santiago Barrio, PhD, Connie Lesnick, Jacqueline C. Barrientos, MD, Susan M. O'Brien, MD, Martin S. Tallman, MD, Mark R. Litzow, MD, Rafael Fonseca, MD, Neil E. Kay, MD, Tait D Shanafelt, MD

Blood (2017) 130 (Supplement 1): 4288.

https://doi.org/10.1182/blood.V130.Suppl_1.4288.4288

Published: 2017

Journal Articles

Safety and Efficacy of Obinutuzumab Plus Fludarabine and Cyclophosphamide in Previously Untreated Patients with Chronic Lymphocytic Leukemia: Subgroup Analysis of the GREEN Study

Veronique Leblond, Guy Cantin, MD, Agostino Cortelezzi, Prof, Wolfgang Knauf, Mourad Tiab, Mehmet Turgut, MD, Andrey Zaritskey, Jean-Louis Merot, Kerstin Trunzer, Susan Robson, Ekaterina Gresko, Stephan Stilgenbauer, MD PhD, Robin Foà, Francesc Bosch

Blood (2017) 130 (Supplement 1): 3015.

https://doi.org/10.1182/blood.V130.Suppl_1.3015.3015

Published: 2017

Journal Articles

The Bloodwise TAP Calibre Feasibility Study to Assess the Mechanism of Action of Idelalisib in B-Cell Receptor Pathway (BCR) Inhibition in Chronic Lymphocytic Leukaemia (CLL)

Talha Munir, Peter Hillmen, MBChB, PhD, Andy Rawstron, PhD, Kristian Brock, MSc, BSc, Samuel Munoz-Vicente, Francesca Yates, PhD, Surita Dalal, PhD, Ruth M de Tute, PhD FRCPath, Chris P Fox, Donald Macdonald, Christopher Fegan, MD, Adrian Bloor, Anna Schuh, MD PhD, Gina Doody

Blood (2017) 130 (Supplement 1): 3014.

https://doi.org/10.1182/blood.V130.Suppl_1.3014.3014

Published: 2017

Journal Articles

The Cytogenetic Aberrations and Their Prognostic Value in 181 Untreated Patients with Lymphoplasmacytic Lymphoma/ Waldenström Macroglobulinemia in China

Wenjie Xiong, Yuting Yan, Shuhua Yi, Zengjun Li, Zhen Yu, Wei Liu, Rui Lv, Dehui Zou, Yan Xu, MD, An Gang, MD, Lugui Qiu, MD

Blood (2017) 130 (Supplement 1): 5160.

https://doi.org/10.1182/blood.V130.Suppl_1.5160.5160

Published: 2017

Journal Articles

Increase of DNA Damage and Alteration of the DNA Damage Response in Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia

Henning D. Popp, MD, Susanne Brendel, MTA, Sabrina Ruppenthal, PhD, Helga Kleiner, MTA, Sven Schneider, MD, Torsten Schulze, MD, Christel Weiss, PhD, Frederik Wenz, MD, Wolf-Karsten Hofmann, MD, Alice Fabarius

Blood (2017) 130 (Supplement 1): 4300.

https://doi.org/10.1182/blood.V130.Suppl_1.4300.4300

Published: 2017

Journal Articles

A Validated Risk Model for Overall Survival in Relapsed/Refractory Chronic Lymphocytic Leukemia Applicable to Patients Treated with Novel Therapies and Standard of Care

Blood (2017) 130 (Supplement 1): 4303.

https://doi.org/10.1182/blood.V130.Suppl_1.4303.4303

Published: 2017

Journal Articles

Fluorescence in-Situ Hybridization (FISH) Analysis in Untreated AL Amyloidosis Has an Independent Prognostic Impact By Abnormality Type and Treatment Category

Blood (2016) 128 (22): 3269.

https://doi.org/10.1182/blood.V128.22.3269.3269

Published: 2016

Journal Articles

Integrative Network Analysis of Newly Diagnosed Multiple Myeloma Identifies a Novel RNA-Seq Based High Riskgene Signature

Alessandro Lagana, PhD, Deepak Perumal, PhD, David Melnekoff, BS, Ben Readhead, MBBS, Brian Kidd, PhD, Violetta V Leshchenko, PhD, Pei-Yu Kuo, MS, Jonathan J Keats, PhD, Mary Derome, MS, Jennifer Yesil, MS, Daniel Auclair, PhD, Deepu Madduri, Ajai Chari, MD, Hearn Jay Cho, MD PhD, Bart Barlogie, MD PhD, Sundar Jagannath, MD, Joel Dudley, PhD, Samir Parekh, MD

Blood (2016) 128 (22): 3285.

https://doi.org/10.1182/blood.V128.22.3285.3285

Published: 2016

NARROW

Rapid Dose Escalation of Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Previously Treated with B-Cell Receptor Inhibitor Therapy

XPO1 Mutations May Identify Binet Α Chronic Lymphocytic Leukemia Patients with Shorter Time to First Treatment

Genomic Abnormalities Among African Individuals with Monoclonal Gammopathies Using Calculated Ancestry

T Cell Large Granular Lymphocytic Leukemia and Co-Existing Plasma Cell Disorders

The Role of Molacular Genetic Examination in Differential Diagnosis and Prognostic Prediction in Patints with B-Cell Chronic Lymphoproliferative Disorders: A Restrospective Study of 1592 Patients

Droplet Digital PCR for the Quantification of Alu Methylation Status in Hematological Malignancies

Cell-Free DNA Analysis Demonstrates Comprehensive Genomic Profiling and a Facile Method to Sensitively in Multiple Myeloma

Predictors of Patient-Reported Communication with Their Health Care Team about New Treatment Options for Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia Patients with IGH Rearrangements Are Characterized By a Distinct Genetic Landscape with Prognostic Implications

Risk of Engraftment Syndrome after Autologous Stem Cell Transplantation for Multiple Myeloma Increases with Age and Lower Dose of CD34+ Cells, but Is Not Impacted By Immunomodulatory Chemotherapy

Chronic Lymphocytic Leukemia with Deletion 13q: Prognostic Predictors and Outcome after Treatment with Fludarabine, Cyclophosphamide and Rituximab (FCR)

Outcomes of Autologous Stem Cell Transplantation in Very Elderly Patients with Multiple Myeloma

Targeted Deep Sequencing in Untreated Progressive CLL Helps to Better Dissect the Genomic Landscape and Shows Novel Associations between Mutations, Prognostic and Clinical Parameters: Data from E1912, a Randomized Phase III Study of the ECOG-ACRIN Cancer Research Group

Safety and Efficacy of Obinutuzumab Plus Fludarabine and Cyclophosphamide in Previously Untreated Patients with Chronic Lymphocytic Leukemia: Subgroup Analysis of the GREEN Study

The Bloodwise TAP Calibre Feasibility Study to Assess the Mechanism of Action of Idelalisib in B-Cell Receptor Pathway (BCR) Inhibition in Chronic Lymphocytic Leukaemia (CLL)

The Cytogenetic Aberrations and Their Prognostic Value in 181 Untreated Patients with Lymphoplasmacytic Lymphoma/ Waldenström Macroglobulinemia in China

Increase of DNA Damage and Alteration of the DNA Damage Response in Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia

A Validated Risk Model for Overall Survival in Relapsed/Refractory Chronic Lymphocytic Leukemia Applicable to Patients Treated with Novel Therapies and Standard of Care

Fluorescence in-Situ Hybridization (FISH) Analysis in Untreated AL Amyloidosis Has an Independent Prognostic Impact By Abnormality Type and Treatment Category

Integrative Network Analysis of Newly Diagnosed Multiple Myeloma Identifies a Novel RNA-Seq Based High Riskgene Signature

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only